Jynarque 60 MG
Ended Awarded
- Contract number
- 36C24521F0461
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,299
Award facts
- Contract value 100% obligated
- $10,298.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Deerfield, IL 60015, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a $10,298.57 firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 60 mg on July 14, 2021, with an ultimate completion date of July 16, 2021. The delivery order was placed to the vendor's location in Riverwoods, Illinois. Jynarque (tolvaptan) is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veterans. This award was issued without any set-aside designation, reflecting Otsuka America's status as an established large pharmaceutical manufacturer with significant federal contracting experience.
This delivery order was issued under Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement (BPA) valued at $83.3 million for Jynarque, awarded by the VA's National Acquisition Center under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with completion through March 26, 2026. The BPA enables VA facilities across multiple Integrated Service Networks to efficiently procure this critical specialty medication. Otsuka America, headquartered in Rockville, Maryland, maintains an established federal supply schedule contract exceeding $396 million for pharmaceuticals and hematology products, supporting the VA's comprehensive healthcare mission to provide specialized pharmaceutical treatments to veterans nationwide.
Quick answers
Who was awarded contract 36C24521F0461?
36C24521F0461 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on July 14, 2021.
How much is contract 36C24521F0461 worth?
The government has obligated $10,299 on 36C24521F0461.
Is contract 36C24521F0461 an order under another contract?
Yes. 36C24521F0461 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24521F0461 competed?
The extent of competition for 36C24521F0461 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award